MVA-5 T 4 immunotherapy ( TroVax ) and low-dose cyclophosphamide for advanced colorectal cancer ( TaCTiCC ) : an open-label , randomized phase 1 / 2 clinical trial

Martin Scurr,Tom Pembroke,Anja Bloom,David Roberts,Amanda Thomson,Kathryn Smart,Hayley Bridgeman, Richard, Adams,Alison Brewster, Robert Jones,Sarah Gwynne, Daniel, Blount,Richard Harrop,Melissa Wright,Robert Hills, Awen, Gallimore,Andrew Godkin

semanticscholar（2019）

Cited 0|Views2

No score

Abstract

Scurr, Martin, Pembroke, Thomas, Bloom, Anja, Roberts, David, Thomson, Amanda, Smart, Kathryn, Bridgeman, Hayley, Admas, Richard, Brewster, Alison, Jones, Robert, Gwynne, Sarah, Blount, Daniel, Harrop, Richard, Wright, Melissa, Hills, Robert, Gallimore, Awen and Godkin, Andrew Effect of Modified Vaccinia Ankara–5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer A Randomized Clinical Trial. JAMA Oncology 3 (10) , e172579. 10.1001/jamaoncol.2017.2579 file

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined